- Active medical implantable devices, which include technologies such as pacemakers, defibrillators, neurostimulators, and cochlear implants, are becoming increasingly essential in managing chronic conditions and improving patient quality of life through continuous monitoring and therapeutic intervention
- The growing demand for these devices is primarily fueled by the rising incidence of cardiovascular and neurological disorders, an aging global population, and increasing patient preference for minimally invasive and long-term treatment solutions
- North America dominated the active medical implantable devices market with the largest revenue share of 40% in 2024, supported by advanced healthcare infrastructure, favorable reimbursement policies, high healthcare spending, and early adoption of innovative implantable technologies, particularly in the United States
- Asia-Pacific is projected to be the fastest growing region in the active medical implantable devices market, during the forecast period due to expanding healthcare access, improving diagnostic capabilities, and growing awareness of chronic disease management
- The minimally invasive surgery segment dominated the active medical implantable devices with a market share of 61.7% in 2024, driven by its reduced recovery time, lower risk of complications, and growing patient preference for less invasive procedures
